Alternatives to estrogen to manage hot flushes

Gynecological Endocrinology

Volumn 20, Issue 1, 2005, Pages 13-21

  Albertazzi, Paola ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Alternative treatment; Climacteric symptoms; Hot flushes; Non estrogen treatment

Indexed keywords

'TAKE CARE'; AGLYCONE; ALPHA TOCOPHEROL; ANGELICA SINENSIS EXTRACT; BIOCHANIN A; CARBOHYDRATE DERIVATIVE; CHINESE DRUG; CIMICIFUGA RACEMOSA EXTRACT; CLONIDINE; DIOSCOREA VILLOSA EXTRACT; ESTROGEN; FLUOXETINE; FUROCOUMARIN; GABAPENTIN; GENISTEIN; GESTAGEN; GLYCOSIDE; ISOFLAVONE; LINSEED OIL; MEDROXYPROGESTERONE ACETATE; PERGOLANEOUM GRAVEOLENS OIL; PHYTOESTROGEN; PLANT EXTRACT; PRIMROSE OIL; PROLACTIN; SALVIA OFFICINALIS EXTRACT; SEROTONIN UPTAKE INHIBITOR; SOYBEAN PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERALIPRIDE; WARFARIN;

ACUPUNCTURE; ACUTE HEPATITIS; ANGELICA SINENSIS; ANOREXIA; ATOPIC DERMATITIS; AUTONOMIC NEUROPATHY; CHINESE MEDICINE; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; CONSTIPATION; CONSULTATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG INDICATION; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG USE; DYSMENORRHEA; ESTROGEN THERAPY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GINSENG; HOT FLUSH; HUMAN; HYPERPROLACTINEMIA; MASTALGIA; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL IRREGULARITY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REBOUND; RED CLOVER; REVIEW; SIDE EFFECT; SYMPTOM; WHEAT; XEROSTOMIA; YAM;

COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PHYTOTHERAPY; PROGESTINS;

EID: 15944379255     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400020799     Document Type: Review

References (89)

1. Shulman LP, Yankov V, Uhl K. Safety and efficacy of a continuous once-a-week 17β-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials. Menopause 2002;3:195-207.
2. Vittinghoff E, Shlipak MG, Varosy PD, Furberg CD, Ireland CC, Khan SS, Blumenthal R, Barrett-Connor E, Hulley S; Heart and Estrogen/progestin Replacement Study Research Group. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2003;138:81-89.
3. Rossouw E, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
4. Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
5. Simon JA, Mack CJ. Counseling patients who elect to discontinue hormone therapy. Int J Fertil Womens Med 2003;48:111-116.
6. Austin PC, Tu K. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study. J Am Med Assoc 2003; 289:3241-3242.
7. Kang HJ, Ansbacher R, Hammoud MM. Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 2002;79:195-207.
8. Seidl MM, Stewart DE. Alternative treatments for menopausal symptoms. Can Fam Physician 1998;44:1271-1276.
9. Kaufert P, Boggs P, Ettinger B, Woods NF, Utian WH. Women and menopause: beliefs, attitudes and behaviors. The North American Menopause Society 1997 survey. Menopause 1997;5:197-202.
10. Glazier M, Gina MB, Bowman M. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001;161: 1161-1172.
11. Dietary Supplement Health and Education Act; 1994. p S784.
12. Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200-2211.
13. Coutrelis N. The legal status and regulatory context of 'health foods' in the European Union. Food Drug Law J 2003;58:35-50.
14. Albertazzi P, Steel SA, Clifford E, Bottazzi M. Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric 2002;5:1-5.
15. Shutt DA. The effects of plant oestrogens of dietary origin. Endevour 1976;35:110-113.
16. Lock M. Encounters with ageing. Mythology of menopause in Japan and North America. Berkeley and Los Angeles: University of California Press Ltd; 1993.
17. Nagata C, Takatsuka N, Shimizu H. Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol 2002;156:824-831.
18. Frost & Sullivan. The European phytonutrients. Market analysis report. UK: Frost & Sullivan; 2002. pp 1.1-1.12.
19. Mintel UK. Vitamins and supplements. Mintel market research. UK: Mintel UK; 2001. p 1-37.
20. Collins BM, McLachlan JA, Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997;62:365-372.
21. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997;389:753-758.
22. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-195.
23. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effects of soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
24. Washburn S, Burke GL, Morgan T, Antony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999;6:7-13.
25. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavones-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001;8:17-26.
26. Kotsopoulus D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms on postmenopausal women. Climacteric 2000;3:161-167.
27. Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavones-containing soy powder dietary supplementation. Climacteric 2001;4:13-18.
28. Scambia G, Mango D, Signorile PG, Anselmi Angeli RA, Palena C, Gallo D, Bombardelli E, Morazzoni P, Riva A, Mancuso S. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;2: 105-111.
29. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FC, Lamia CA. Vasomotor symptoms relief by soy isoflavone extract tablets in postmenopausal women; a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000;7:236-242.
30. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389-394.
31. Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2002;9: 329-334.
32. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptom in women. Climacteric 1999;2:85-92.
33. Knight DC, Howes JB, Eden JA. The effects of Promensil™, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
34. van de Weijer PH, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo Maturitas 2002;42:187-193.
35. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. J Am Med Assoc 2003;290:207-214.
36. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol 2000;5:1068-1074.
37. Van Patten CL, Olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E, Wattie A, Prior JC. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002;20:1449-1455.
38. Setchell KD, Cole SJ. Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labelling. Agric Food Chem 2003;51:4146-4155.
39. Setchell KD, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, Heubi JE. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002;76:447-453.
40. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors α and β. Biol Pharm Bull 2001;24:351-356.
41. Tokudome S, Nagaya T, Okuyama H, Tokudome Y, Imaeda N, Kitagawa I, Fujiwara N, Ikeda M, Goto C, Ichikawa H, et al. Japanese versus Mediterranean Diets and Cancer. Asian Pac J Cancer Prev 2000;1:61-66.
42. Albertazzi P, Coupland K. Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 2002;42:13-22.
43. Pepping J. Black cohosh: Cimicifuga racemosa. Am J Health Sust Pharm 1999;56:1400-1402.
44. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(1 Suppl):S67-S77.
45. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739-2745.
46. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002;177:440-443.
47. Zhu D. Dong quai. Am J Chin Med 1987;15:117-125.
48. Hardy M. Herbs of special interest to women. J Am Pharm Assoc 2000;40:234-242.
49. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997;68:981-986.
50. Seibel MM. Treating hot flushes without hormone replacement therapy. J Fam Pract 2003;52:291-296.
51. Chenoy R, Hussain S, Tayob Y, O'Brien PM, Moss MY, Morse PF. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. Br Med J 1994;308: 501-503.
52. Wiklund IK, Mattsson LA, Lindgren R, Umoni C. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 1999;19:89-99.
53. Zell B, Hirata J, Marcus A, Ettinger B, Pressman A, Ettinger KM. Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners. Menopause 2000;7:129-134.
54. Meydani M. The Boyd Orr lecture. Nutrition interventions in aging and age-associated disease. Proc Nutr Soc 2002; 61:165-171.
55. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495-500.
56. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. J Am Med Assoc 1980;244:1443-1445.
57. Aslaksen K, Frankendal B. Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1982; 61:423-428.
58. Bertelli G, Venturini M, Del Mastro L, Bergaglio M, Sismondi P, Biglia N, Venturini S, Porcile G, Pronzato P, Costantini M, et al. Intramuscular depot medroxyprogesterone versus oral mergestrol for the control of postmenopausal hot flushes in breast cancer patients: a randomized study. Ann Oncol 2002;13:883-888.
59. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, et al. Mergestrol acetate for the prevention of hot flushes. N Engl J Med 1994;331:347-352.
60. Peterson CM. Progestogens, progesterone antagonists, progesterone and androgens: synthesis, classification and uses. Clin Obstet Gynecol 1995;38:813-320.
61. BioLogic Health Solutions. How BioGest® Menopause Relief works. Redhill, QLD, Australia: BioLogic; 2004 [cited 2004 Nov 11]. Available from: http://www.biogest.net/content/m_how.html
62. Denwick PM. Pharmaceutical steroids and their production for hormone replacement therapy. J Br Menopause Soc 1999;5:12-22.
63. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999;94:225-228.
64. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001;4:144-150.
65. Berendsen HHG. Hot flushes and serotonin. J Br Menopause Soc 2002;8:30-34.
66. Berendsen HH, Weekers AH, Kloosterboer HJ. Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. Eur J Pharmacol 2001;419:47-54.
67. Pandya KJ, Raubertas RF, Flynn PJ, Hynes HE, Rosenbluth RJ, Kirshner JJ, Pierce HI, Dragalin V, Morrow GR. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000;132:788-793.
68. David A, Don R, Tajchner G, Weissglas L. Veralipride: alternative antidopaminergic treatment for menopausal symptoms. Am J Obstet Gynecol 1988;158:1107-1111.
69. Verbeke K, Dhont M, Vandekerckhove D. Clinical and hormonal effects of long-term veralipride treatment in postmenopausal women. Maturitas 1988;10:225-230.
70. Guttuso TJ Jr. Gabapentin's effects on hot flashes and hypothermia. Neurology 2000;54:2161-2163.
71. Albertazzi P, Bottazzi M, Purdie DW. Gabapentin for the management of hot flushes: a case series. Menopause 2003;10:214-217.
72. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-345.
73. Berendsen HH. The role of serotonin in hot flushes. Maturitas 2000;36:155-164.
74. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-2063.
75. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-1583.
76. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;4:337-345.
77. Pansini F, Albertazzi P, Bonaccorsi G, Zanotti L, Porto S, Dossi L, Campobasso C, Mollica G. Trazodone: a non-hormonal alternative for neurovegetative climacteric symptoms. Clin Exp Obstet Gynecol 1995;22:341-344.
78. Waldinger MD, Berendsen HH, Schweitzer DH. Treatment of hot flushes with mirtazapine: four case reports. Maturitas 2000;36:165-168.
79. Shaw CR. The perimenopausal hot flush: epidemiology, physiology and treatment. Nurs Pract 1997;55:61-66.
80. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990;69:409-412.
81. Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997;16:203-208.
82. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998;29:139-146.
83. Stevenson DW, Delprato DJ. Multiple component self-control program for menopausal hot flashes. J Behav Ther Exp Psychiatry 1983;2:137-140.
84. Wijma K, Melin A, Nedstrand E, Hammar M. Treatment of menopausal symptoms with applied relaxation: a pilot study. J Behav Ther Exp Psychiatry 1997;28:251-261.
85. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation of ambulatory monitoring. Am J Obstet Gynecol 1992;167:436-439.
86. Hunter MS. A treatment option for menopausal hot flushes: cognitive relaxation therapy. Eur Menopause J 1995;2:16-17.
87. Carpenter JS, Wells N, Lambert B, Watson P, Slayton T, Chak B, Hepworth JT, Worthington WB. A pilot study of magnetic therapy for hot flashes after breast cancer. Cancer Nurs 2002;25:104-109.
88. Porzio G, Trapasso T, Martelli S, Sallusti E, Piccone C, Mattel A, Di Stanislao C, Ficorella C, Marchetti P. Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori 2002;88:128-130.
89. Dong H, Ludicke F, Comte I, Campana A, Graff P, Bischof P. An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med. 2001;7:651-658